News

U.S. Dermatology Partners Opens New Office in Sterling, CO

U.S. Dermatology Partners Opens New Office in Sterling, CO

U.S. Dermatology Partners Expands Reach in Colorado

U.S. Dermatology Partners is committed to enhancing access to dermatology care for patients in various regions with the exciting opening of its newest office in Sterling, Colorado. The company aims to address skin health issues for individuals of all ages by providing essential dermatologic services.

Services Offered at the Sterling Location

The new facility will begin treating patients starting December 20, 2024. It will cover a wide range of dermatologic conditions, including treating conditions such as acne, eczema, rosacea, and skin cancer. This expansion signifies a major step forward in offering specialized healthcare to the residents.

Leadership and Expertise

At the helm of this new location is Physician's Assistant Casey Busmente. With a strong background in patient care, Casey brings over 15 years of experience that positions her as a vital member of the community. Armed with a Bachelor’s degree from the University of South Dakota and a physician assistant degree from the University of Colorado, Casey has undergone extensive training in dermatology, including hands-on experience in one of the state's leading centers.

Enhancing Community Health

“We are thrilled with the opportunity to bring our premier dermatological services to the patients of this community,” said Paul Singh, CEO of U.S. Dermatology Partners. His vision emphasizes making high-quality care more accessible and ensuring that residents receive the attention they deserve.

Future Expansion Plans

The establishment of the Sterling office is part of U.S. Dermatology Partners’ strategic plan to launch over 30 new locations across eight states through 2024. This initiative is designed to improve patient access to dermatologic care, making it more convenient for individuals to receive the treatments they need.

Discover Sterling, Colorado

Sterling stands as the county seat of Logan County and serves as a vibrant municipality in Northeastern Colorado, often referred to as the "Queen City of the Plains." Known for its rich history, Sterling offers visitors a range of cultural experiences, including museums and historical features, as well as stunning natural landscapes. The newly opened office is located in a prime area on Main Street, making it easy for patients to access necessary medical care.

Location and Accessibility

The new U.S. Dermatology Partners office is conveniently situated at 519 W Main Street, Suite B, Sterling, Colorado 80751. This accessible position allows for seamless patient visits, and the staff is dedicated to accommodating the schedules of individuals year-round.

Contacting U.S. Dermatology Partners

To learn more about the services offered or to schedule an appointment, individuals can reach out by calling (970) 425-3092 or visit the website online to request an appointment. This user-friendly approach is part of the commitment to ensuring patients receive timely care without hassle.

About U.S. Dermatology Partners

As one of the nation's leading dermatology practices, U.S. Dermatology Partners serves over 2 million patients annually. With more than 100 locations that span urban and rural areas across eight states, the organization focuses on delivering tailored, patient-centered care. They strive to simplify access to dermatologists and specialists, offering cutting-edge treatments that encompass surgical, clinical, and cosmetic dermatology. Their dedication to patient-first care makes them a trusted name in dermatologic health.

Frequently Asked Questions

What services are available at the new Sterling, Colorado office?

The Sterling office will offer treatments for various dermatologic conditions, including acne, eczema, rosacea, and skin cancer.

Who will be leading the new location?

Physician's Assistant Casey Busmente, with over 15 years of experience, will lead the Sterling location.

When will the Sterling office open?

The Sterling office is set to open on December 20, 2024.

Where is the Sterling office located?

The new office is located at 519 W Main Street, Suite B, Sterling, Colorado 80751.

How can I schedule an appointment at U.S. Dermatology Partners?

To schedule an appointment, you can call (970) 425-3092 or visit their website to request an appointment online.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Mobilize for Action Against Organon & Co. (OGN) Claims

Updated Category News Views 248

Mobilizing for Justice: Organon & Co. Class Action Lawsuit Overview Recent developments have drawn serious attention to Organon & Co. (NYSE: OGN), as investors set their sights on a class action lawsuit aimed at seeking justice for significant financial losses incurred. The legal proceedings are a reaction to purported misleading statements made by the company’s...

Continue Reading
Humana's 2024 Third Quarter Results Show Financial Resilience

Updated Category News Views 107

Humana Reports Third Quarter Financial Results for 2024 Humana Inc. (NYSE: HUM) has recently disclosed its consolidated financial results for the third quarter of 2024, highlighting a comprehensive overview of its performance compared to the previous year. Despite prevailing challenges within the healthcare sector, the organization showcased solid financial resilience and...

Continue Reading
CobbleStone Joins Civic Marketplace for Easy Gov't Procurement

Updated Category News Views 21

CobbleStone Software Goes Digital with Civic Marketplace Sometimes in this tech-driven world, it feels like the old-school bureaucratic processes just can't keep up. Enter CobbleStone Software, a name that's ringing bells in the halls of government offices with a neat little trick up its sleeve: integrating its contract management platform into the Civic Marketplace. It's...

Continue Reading
Shineco Inc Faces Stock Challenges Amid Recovery Efforts

Updated Category News Views 186

Shineco Inc Stock Experiences Significant Decline Shineco Inc (SISI) has reached a concerning milestone as its stock plummets to a 52-week low at $1.92. With a market capitalization of only $3.64 million, this dip reveals ongoing issues within the company's financial landscape. Analysts have pegged its financial health score as 'WEAK', bringing to light several risk...

Continue Reading
Epsilon Energy Reflects on Strategic Acquisitions in Oil and Gas

Updated Category News Views 254

Epsilon Energy’s Latest Strategic Acquisition Epsilon Energy Ltd. (NASDAQ: EPSN), a prominent player in North American onshore natural gas and oil production, has completed significant acquisitions, marking an important chapter in the company’s expansion strategy. Through the recent purchase of Peak Exploration and Production LLC and Peak BLM Lease LLC, referred to as...

Continue Reading